In this study, researchers aimed to characterize the relationship between major depressive disorder, use of antidepressants, and risk of recurrence in breast cancer patients.
Childhood sexual abuse and paternal death are among the strongest predictors for developing major depressive disorder later ...
PsyPost on MSN
Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder
A recent study published in Nature Medicine suggests that a brief psychedelic experience combined with talk therapy can ...
An integrative Translational Psychiatry study linked BPA exposure to major depressive disorder by identifying 571 shared ...
Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto ...
No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...
Commercial agreement serves as high-profile third party validation of BullFrog AI's proprietary capabilities Agreement utilizes BullFrog AI's end-to-end analytical AI platform to accelerate drug ...
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
Bullfrog AI Holdings, Inc. BFRG shares are trading higher on continued strength Tuesday after the company announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results